The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic

James F. Meschia; Kevin M. Barrett; Robert D. Brown; Tanya N. Turan; Virginia J. Howard; Jenifer H. Voeks; Brajesh K. Lal; George Howard; Thomas G. Brott

doi:10.1212/WNL.0000000000009698

The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic

James F. Meschia, Kevin M. Barrett, Robert D. Brown, Tanya N. Turan, Virginia J. Howard, Jenifer H. Voeks, Brajesh K. Lal, George Howard, Thomas G. Brott

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The coronavirus disease 2019 pandemic has disrupted the lives of whole communities and nations. The multinational multicenter National Institute of Neurological Disorders and Stroke Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial stroke prevention trial rapidly experienced the effects of the pandemic and had to temporarily suspend new enrollments and shift patient follow-up activities from in-person clinic visits to telephone contacts. There is an ethical obligation to the patients to protect their health while taking every feasible step to ensure that the goals of the trial are successfully met. Here, we describe the effects of the pandemic on the trial and steps that are being taken to mitigate the effects of the pandemic so that trial objectives can be met.

Original language	English (US)
Pages (from-to)	29-36
Number of pages	8
Journal	Neurology
Volume	95
Issue number	1
DOIs	https://doi.org/10.1212/WNL.0000000000009698
State	Published - Jul 7 2020

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000009698

Cite this

@article{c297870d94944b8aa848f0bc861299d5,

title = "The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic",

abstract = "The coronavirus disease 2019 pandemic has disrupted the lives of whole communities and nations. The multinational multicenter National Institute of Neurological Disorders and Stroke Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial stroke prevention trial rapidly experienced the effects of the pandemic and had to temporarily suspend new enrollments and shift patient follow-up activities from in-person clinic visits to telephone contacts. There is an ethical obligation to the patients to protect their health while taking every feasible step to ensure that the goals of the trial are successfully met. Here, we describe the effects of the pandemic on the trial and steps that are being taken to mitigate the effects of the pandemic so that trial objectives can be met.",

author = "Meschia, {James F.} and Barrett, {Kevin M.} and Brown, {Robert D.} and Turan, {Tanya N.} and Howard, {Virginia J.} and Voeks, {Jenifer H.} and Lal, {Brajesh K.} and George Howard and Brott, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} 2020 American Academy of Neurology.",

year = "2020",

month = jul,

day = "7",

doi = "10.1212/WNL.0000000000009698",

language = "English (US)",

volume = "95",

pages = "29--36",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - The CREST-2 experience with the evolving challenges of COVID-19

T2 - A clinical trial in a pandemic

AU - Meschia, James F.

AU - Barrett, Kevin M.

AU - Brown, Robert D.

AU - Turan, Tanya N.

AU - Howard, Virginia J.

AU - Voeks, Jenifer H.

AU - Lal, Brajesh K.

AU - Howard, George

AU - Brott, Thomas G.

PY - 2020/7/7

Y1 - 2020/7/7

N2 - The coronavirus disease 2019 pandemic has disrupted the lives of whole communities and nations. The multinational multicenter National Institute of Neurological Disorders and Stroke Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial stroke prevention trial rapidly experienced the effects of the pandemic and had to temporarily suspend new enrollments and shift patient follow-up activities from in-person clinic visits to telephone contacts. There is an ethical obligation to the patients to protect their health while taking every feasible step to ensure that the goals of the trial are successfully met. Here, we describe the effects of the pandemic on the trial and steps that are being taken to mitigate the effects of the pandemic so that trial objectives can be met.

AB - The coronavirus disease 2019 pandemic has disrupted the lives of whole communities and nations. The multinational multicenter National Institute of Neurological Disorders and Stroke Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial stroke prevention trial rapidly experienced the effects of the pandemic and had to temporarily suspend new enrollments and shift patient follow-up activities from in-person clinic visits to telephone contacts. There is an ethical obligation to the patients to protect their health while taking every feasible step to ensure that the goals of the trial are successfully met. Here, we describe the effects of the pandemic on the trial and steps that are being taken to mitigate the effects of the pandemic so that trial objectives can be met.

UR - http://www.scopus.com/inward/record.url?scp=85087736528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087736528&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000009698

DO - 10.1212/WNL.0000000000009698

M3 - Article

C2 - 32358216

AN - SCOPUS:85087736528

SN - 0028-3878

VL - 95

SP - 29

EP - 36

JO - Neurology

JF - Neurology

IS - 1

ER -

The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this